Abstract
The present study is a trial to suppress or attenuate the cardiotoxicity of catecholamines, which have been developed synthetically for the treatment of several cardiovascular disorders and conditions such as asthma and nasal congestion. Epinephrine (Adrenaline) is the most commonly available inotrope and in many cases the most appropriate drug to maintain blood pressure. However, tachycardia, ventricular arrhythmias and hypertension are side effects of this drug. In this investigation, induction of catecholamines cardiotoxicity was experimentally achieved using epinephrine. In isolated toads’hearts, the cardiac arrhythmias produced by different concentrations of epinephrine (10, 50, 100, 200 and 300 ng mlG ) 1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
